journal article·2022-10-19

Upconversion Optogenetic Engineered Bacteria System for Time-Resolved Imaging Diagnosis and Light-Controlled Cancer Therapy

Yingying Zhang, Xin Xue, Mingxi Fang, Gaoju Pang, Yujuan Xing, Xinyu Zhang, Lianyue Li, Qu Chen, Yuxin Wang, Jin Chang, Peiqi Zhao, Hanjie Wang

ACS Applied Materials & Interfaces· Volume 14· Issue 41
Publisher page

Abstract

Engineering bacteria can achieve targeted and controllable cancer therapy using synthetic biology technology and the characteristics of tumor microenvironment. Besides, the accurate tumor diagnosis and visualization of the treatment process are also vital for bacterial therapy. In this paper, a light control engineered bacteria system based on upconversion nanoparticles (UCNP)-mediated time-resolved imaging (TRI) was constructed for colorectal cancer theranostic and therapy. UCNP with different luminous lifetimes were separately modified with the tumor targeting molecule (folic acid) or anaerobic bacteria (Nissle 1917, EcN) to realize the co-localization of tumor tissues, thus improving the diagnostic accuracy based on TRI. In addition, blue light was used to induce engineered bacteria (EcN-pDawn-φx174E/TRAIL) lysis and the release of tumor apoptosis-related inducing ligand (TRAIL), thus triggering tumor cell death. In vitro and in vivo results indicated that this system could achieve accurate tumor diagnosis and light-controlled cancer therapy. EcN-pDawn-φx174E/TRAIL with blue light irradiation could inhibit 53% of tumor growth in comparison to that without blue light irradiation (11.8%). We expect that this engineered bacteria system provides a new technology for intelligent bacterial therapy and the construction of cancer theranostics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu 221004, People’s Republic of China

School of Life Sciences, Tianjin University and Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin 300072, People’s Republic of China

Department of Lymphoma, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300060, People’s Republic of China

Funding

Ministry of Science and Technology of the People's Republic of China · Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China · Jiangsu Province Colleges and Universities · Startup Fund for Youth Talent in Xuzhou Medical University · Integrated Innovation Project in Xuzhou Medical University · Key Research and Development Program of Tianjin

References (33)

Show source-provided references
1. 10.1002/adfm.20190980610.1002/adfm.201909806 ↗
2. 10.1016/j.biomaterials.2019.11922610.1016/j.biomaterials.2019.119226 ↗
3. 10.1016/j.biomaterials.2022.12158210.1016/j.biomaterials.2022.121582 ↗
4. 10.1021/acsnano.8b0223510.1021/acsnano.8b02235 ↗
5. 10.1002/advs.20200476910.1002/advs.202004769 ↗
6. 10.1038/s12276-019-0297-010.1038/s12276-019-0297-0 ↗
7. 10.1002/adfm.20190662310.1002/adfm.201906623 ↗
8. 10.1002/advs.20220171110.1002/advs.202201711 ↗
9. 10.1021/acsnano.1c0560510.1021/acsnano.1c05605 ↗
10. 10.1002/anie.20220240910.1002/anie.202202409 ↗
11. 10.1126/scitranslmed.aax087610.1126/scitranslmed.aax0876 ↗
12. 10.1038/s41586-021-04003-210.1038/s41586-021-04003-2 ↗
13. 10.1038/s41551-022-00886-210.1038/s41551-022-00886-2 ↗
14. 10.1038/s41551-021-00772-310.1038/s41551-021-00772-3 ↗
15. 10.1016/j.celrep.2020.02.03310.1016/j.celrep.2020.02.033 ↗
16. 10.1021/acssynbio.1c0045210.1021/acssynbio.1c00452 ↗
17. 10.1038/s41589-021-00787-610.1038/s41589-021-00787-6 ↗
18. 10.1038/nature1893010.1038/nature18930 ↗
19. 10.1038/s41467-022-29065-210.1038/s41467-022-29065-2 ↗
20. 10.1038/s41587-022-01244-y10.1038/s41587-022-01244-y ↗
21. 10.1126/scitranslmed.aaa351910.1126/scitranslmed.aaa3519 ↗
22. 10.1021/acs.nanolett.1c0403710.1021/acs.nanolett.1c04037 ↗
23. 10.1002/adfm.20200826210.1002/adfm.202008262 ↗
24. 10.1002/smll.20180496910.1002/smll.201804969 ↗
25. 10.1002/anie.20180288910.1002/anie.201802889 ↗
26. 10.1002/adma.20200485310.1002/adma.202004853 ↗
27. 10.1038/s41566-019-0437-z10.1038/s41566-019-0437-z ↗
28. 10.1039/C6SC03667H10.1039/C6SC03667H ↗
29. 10.1038/s41467-019-13796-w10.1038/s41467-019-13796-w ↗
30. 10.1038/nphoton.2013.32210.1038/nphoton.2013.322 ↗
31. 10.1126/sciadv.aba273510.1126/sciadv.aba2735 ↗
32. 10.1016/j.nantod.2021.10126410.1016/j.nantod.2021.101264 ↗
33. 10.1016/j.cej.2021.13084210.1016/j.cej.2021.130842 ↗